Huntsman Cancer Institute's Hematology Program treats a wide variety of hematological conditions.
Hematological Cancers
- Acute leukemias, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), acute myelomonocytic leukemia (AMML), and acute promyelocytic leukemia (APML)
- Amyloidosis
- Castleman's disease
- Chronic leukemias such as chronic lymphocytic leukemia (CLL) and chronic myelogenous leukemia (CML)
- Lymphomas (Hodgkin lymphoma and Non-Hodgkin lymphoma, including B-cell and T-cell lymphomas
- Monoclonal gammopathies
- Myelodysplastic syndromes (MDS)
- Multiple myeloma
- Myeloproliferative dysplasia (MPD)
- Plasma cell neoplasms
Benign Hematological Disorders
- Autoimmune-induced disorders such as hemolytic anemia, Evan's syndrome, immune thrombocytopenic purpura (ITP), and sarcoidosis
- Bleeding or clotting disorders
- Iron metabolism disorders such as hemochromatosis and porphyria
- Mastoctytosis, including systemic mastocytosis
- Metabolic disorders such as Gaucher disease
- Myeloproliferative disorders such as polycythemia vera, essential thrombocytosis, and myelofibrosis
- Pancytopenia
- Plasma cell and antibody production disorders (benign monoclonal gammopathy [MGUS], cryoglobulinemia, and amyloidosis)
- Platelet disorders
- Polyclonal gammopathy
- Red blood cell disorders such as anemias, spherocytosis, and myelodysplasia
- Thrombotic disorders such as paroxysmal nocturnal hemoglobinuria, factor V Leiden, and antiphospholipid syndrome
- White blood cell disorders such as neutropenia, leucopenia, monocytosis, and leukocytosis
